Salarius Pharmaceuticals Inc • SLRX

Capital at risk.

About Salarius Pharmaceuticals Inc
Ticker
info
SLRX
Trading on
info
NASDAQ
ISIN
info
US79400X4043
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Mark J. Rosenblum CPA
Headquarters
info
2450 Holcombe Blvd., Houston, TX, United States, 77021
Employees
info
2
Website
info
salariuspharma.com
Salarius Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing treatments for cancers with unmet medical need. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds and Cancer Prevention and Research Institute of Texas for product development activities. The company is based in Houston, Texas.
Metrics
BasicAdvanced
Market cap
info
$3.2M
P/E ratio
info
-
EPS
info
-$23.70
Dividend Yield
info
0.00%
Beta
info
0.33
Forward P/E ratio
info
0
EBIDTA
info
$-5.7M
Ex dividend date
info
-
Price & volume
Market cap
info
$3.2M
Average daily volume
info
0.2M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
0
Trailing P/E
info
0
Price to sales
info
18.12
Price to book
info
67.97
Earnings
EPS
info
-$23.70
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-5.7M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
0.33
52-week High
info
$55.05
52-week Low
info
$2.82
50-day moving average
info
$4.39
200-day moving average
info
$12.04
Short ratio
info
0.81
Short %
info
33.50%
Management effectiveness
ROE (TTM)
info
-660.37%
ROA (TTM)
info
-143.52%
Profit margin
info
0.00%
Gross profit margin
info
$-15.8M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
-100.00%
Share stats
Outstanding Shares
info
1.1M
Float
info
0M
Insiders %
info
0.14%
Institutions %
info
2.51%
Analyst Insights & forecasts
info

0% Buy

100% Hold

0% Sell

Based on information from 1 analysts.

Average price target

info
$26.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$11.40
-$804.00
98.58%
Q3 • 24Beat
-$1.01
-$0.74
-36.49%
Q4 • 24Missed
-$1.02
-$1.03
1.38%
Q1 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-1.7M
-∞%
Q1 • 25
$0M
$-1M
-∞%
Q2 • 25
NaN%
-43.97%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$2.3M
$2.3M
97.36%
Q1 • 25
$1.4M
$2.2M
159.57%
Q2 • 25
-40.46%
-2.42%
63.91%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-1.2M
-
$0.5M
$-1.2M
Q1 • 25
$-0.9M
-
$-0.1M
$-0.9M
Q2 • 25
-27.03%
-
-125.88%
-27.03%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Salarius Pharmaceuticals Inc share?
Collapse

Salarius Pharmaceuticals Inc shares are currently traded for undefined per share.

How many shares does Salarius Pharmaceuticals Inc have?
Collapse

Salarius Pharmaceuticals Inc currently has 1.1M shares.

Does Salarius Pharmaceuticals Inc pay dividends?
Collapse

No, Salarius Pharmaceuticals Inc doesn't pay dividends.

What is Salarius Pharmaceuticals Inc 52 week high?
Collapse

Salarius Pharmaceuticals Inc 52 week high is $55.05.

What is Salarius Pharmaceuticals Inc 52 week low?
Collapse

Salarius Pharmaceuticals Inc 52 week low is $2.82.

What is the 200-day moving average of Salarius Pharmaceuticals Inc?
Collapse

Salarius Pharmaceuticals Inc 200-day moving average is $12.04.

Who is Salarius Pharmaceuticals Inc CEO?
Collapse

The CEO of Salarius Pharmaceuticals Inc is Mark J. Rosenblum CPA.

How many employees Salarius Pharmaceuticals Inc has?
Collapse

Salarius Pharmaceuticals Inc has 2 employees.

What is the market cap of Salarius Pharmaceuticals Inc?
Collapse

The market cap of Salarius Pharmaceuticals Inc is $3.2M.

What is the P/E of Salarius Pharmaceuticals Inc?
Collapse

The current P/E of Salarius Pharmaceuticals Inc is null.

What is the EPS of Salarius Pharmaceuticals Inc?
Collapse

The EPS of Salarius Pharmaceuticals Inc is -$23.70.

What is the PEG Ratio of Salarius Pharmaceuticals Inc?
Collapse

The PEG Ratio of Salarius Pharmaceuticals Inc is 0.

What do analysts say about Salarius Pharmaceuticals Inc?
Collapse

According to the analysts Salarius Pharmaceuticals Inc is considered a hold.